marginally significantp = 0.068
While no statistically significant interaction was observed between HIV status and either treatment or cancer stage, there was a marginally significant survival benefit for HIV-positive patients diagnosed at Stage 1 (HR = 0.38, 95% CI: 0.13–1.07, p = 0.068).